Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation
Authors:
- Rowan S HardyRHRowan S Hardy
- Andrew FilerAFAndrew Filer
- Mark S CooperMCMark S Cooper
- Greg ParsonageGPGreg Parsonage
- Karim RazaKRKarim Raza
- Debbie L HardieDHDebbie L Hardie
- Elizabeth H RabbittERElizabeth H Rabbitt
- Paul M StewartPSPaul M Stewart
- Christopher D BuckleyCBChristopher D Buckley
- Martin HewisonMHMartin Hewison
Open Access
- 17 July 2006
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 8 (4) , R108
Abstract
Stromal cells such as fibroblasts play an important role in defining tissue-specific responses during the resolution of inflammation. We hypothesized that this involves tissue-specific regulation of glucocorticoids, mediated via differential regulation of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Expression, activity and function of 11β-HSD1 was assessed in matched fibroblasts derived from various tissues (synovium, bone marrow and skin) obtained from patients with rheumatoid arthritis or osteoarthritis. 11β-HSD1 was expressed in fibroblasts from all tissues but mRNA levels and enzyme activity were higher in synovial fibroblasts (2-fold and 13-fold higher mRNA levels in dermal and synovial fibroblasts, respectively, relative to bone marrow). Expression and activity of the enzyme increased in all fibroblasts following treatment with tumour necrosis factor-α or IL-1β (bone marrow: 8-fold and 37-fold, respectively, compared to vehicle; dermal fibroblasts: 4-fold and 14-fold; synovial fibroblasts: 7-fold and 31-fold; all P < 0.01 compared with vehicle). Treatment with IL-4 or interferon-γ was without effect, and there was no difference in 11β-HSD1 expression between fibroblasts (from any site) obtained from patients with rheumatoid arthritis or osteoarthritis. In the presence of 100 nmol/l cortisone, IL-6 production – a characteristic feature of synovial derived fibroblasts – was significantly reduced in synovial but not dermal or bone marrow fibroblasts. This was prevented by co-treatment with an 11β-HSD inhibitor, emphasizing the potential for autocrine activation of glucocorticoids in synovial fibroblasts. These data indicate that differences in fibroblast-derived glucocorticoid production (via the enzyme 11β-HSD1) between cells from distinct anatomical locations may play a key role in the predeliction of certain tissues to develop persistent inflammation.Keywords
This publication has 46 references indexed in Scilit:
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1Journal of Molecular Endocrinology, 2005
- 11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid ResponseEndocrine Reviews, 2004
- The Functional Consequences of 11β-Hydroxysteroid Dehydrogenase Expression in Adipose TissueHormone and Metabolic Research, 2002
- The Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single GeneMolecular Endocrinology, 2002
- 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN DIFFERENTIATING OMENTAL HUMAN PREADIPOCYTES: FROM DE-ACTIVATION TO GENERATION OF CORTISOLEndocrine Research, 2002
- Hypothalamic–pituitary–adrenal axis regulation of inflammation in rheumatoid arthritisImmunology & Cell Biology, 2001
- Minireview: 11β-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action1Endocrinology, 2001
- Growth Hormone, Insulin-Like Growth Factor-I and the Cortisol-Cortisone ShuttleHormone Research in Paediatrics, 2001
- Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-κB and Steroid Receptor-Signaling PathwaysEndocrine Reviews, 1999